MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED
The main activities of the Charity are applying for funding and project managing clinical trials in Africa in relation to 'neglected diseases' (including riverblindness); researching the causes, prevention or cure of diseases; researching existing and potential new medicines and vaccines for the prevention or cure of diseases; developing existing and new medicines and vaccines.
Objects
THE ADVANCEMENT OF HEALTH AND THE SAVING OF LIVES FOR THE BENEFIT OF THE PUBLIC BY: 1. PREVENTING AND RELIEVING SICKNESS, DISEASE OR HUMAN SUFFERING; 2. CONDUCTING RESEARCH INTO THE CAUSES, PREVENTION OR CURE OF DISEASE IN HUMAN BEINGS; 3. CONDUCTING RESEARCH INTO EXISTING AND POTENTIAL NEW MEDICINES AND VACCINES AND THEIR USES FOR THE PREVENTION OR CURE OF DISEASE IN HUMAN BEINGS; AND 4. DEVELOPING EXISTING AND POTENTIAL NEW MEDICINES AND VACCINES FOR HUMAN USE FOR THE PREVENTION OR CURE OF DISEASE.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net deficit of £5,324 for the year ended 30 June 2025, resulting in accumulated restricted funds of £122,162. The trustees note that the charity relies on the continued backing and support of an associated Australian charity to maintain adequate resources for going concern purposes.
What the accounts disclose
“The trustees will aim to have a Reserves Policy in place within the next two years, however, the target will be so have a minimum of £70k to cover three months expenditure.” — page 4
“The UK charity is associated with an Australian charity of the same name. As at 30 June 2025. as disclosed in note 9 above, the UK charity owed the Australian charity £279,350 (2024 - £279,350) . This debt mainly arose in prior periods before the UK company obtained charitable status. The Australian charity underwrites the UK charity by continually extending credit on this debt and waiving elements if it is deemed appropriate.” — page 16
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Risk management
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Social media policy and procedures
Funders the charity credits
- European & Developing Countries Clinical Trials Partnership (EDCTP)
- European Union
Trustees
- Sara Kate Antrobuschair
- Dr Lorna Agnes Meldrum
- Dr Michael John Elliott
- Prof Andrew Frederick Wilks
- Professor Mark Thomas Sullivan AO
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/06/2025 | £111k | £117k |
| 30/06/2024 | £262k | £144k |
| 30/06/2023 | £350k | £289k |
Common questions
Is MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net deficit of £5,324 for the year ended 30 June 2025, resulting in accumulated restricted funds of £122,162. The trustees note that the charity relies on the continued backing and support of an associated Australian charity to maintain adequate resources for going concern purposes. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE CHILDREN'S INVESTMENT FUND FOUNDATION (UK) | 1 | £17.9m |
| THE VIRGIN FOUNDATION | 1 | £2.8m |
| MOONDANCE FOUNDATION | 1 | £2.0m |
| ORPHANS IN NEED | 1 | £1.6m |
| EFFECTIVE VENTURES FOUNDATION | 1 | £1.4m |
| DELTA PHILANTHROPIES | 1 | £1.3m |
| THE SEQUOIA TRUST | 1 | £775k |
| JAMES PERCY FOUNDATION | 1 | £566k |
Charities like this
- TRES CANTOS OPEN LAB FOUNDATION
- MALARIA CONSORTIUM
- THE END FUND
- MEDEWELL INTERNATIONAL
- THE LORNA AND YUTI CHERNAJOVSKY BIOMEDICAL RESEARCH FOUNDATION
- AIDS HEALTHCARE FOUNDATION UK
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED | £111k | — | 0 | below | — | no doubt |
| TRES CANTOS OPEN LAB FOUNDATION | £952k | — | 0 | unclear | — | no doubt |
| MALARIA CONSORTIUM | £99.4m | — | — | above | — | no doubt |
| THE END FUND | £3.5m | — | 0 | above | — | no doubt |
| MEDEWELL INTERNATIONAL | £198k | — | 0 | unclear | 0.0% | no doubt |
| THE LORNA AND YUTI CHERNAJOVSKY BIOMEDICAL RESEARCH FOUNDATION | £526k | — | 0 | above | — | no doubt |